An Open-Label Study of Apabetalone in Covid Infection
Condition(s):COVID-19 InfectionLast Updated:November 18, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):COVID-19 InfectionLast Updated:November 18, 2023Terminated
Condition(s):Fabry DiseaseLast Updated:November 18, 2023Withdrawn
Condition(s):Kidney Failure, ChronicLast Updated:November 15, 2023Not yet recruiting
Condition(s):Diabetes Mellitus, Type 2; Coronary Artery DiseaseLast Updated:August 20, 2021Completed
Condition(s):Dyslipidemia; Coronary Artery DiseaseLast Updated:May 12, 2015Terminated
Condition(s):DiabetesLast Updated:April 2, 2014Completed
Condition(s):Coronary Artery Disease; DyslipidemiaLast Updated:September 20, 2012Completed
Condition(s):Coronary Artery DiseaseLast Updated:June 4, 2013Completed
Condition(s):Atherosclerosis; Coronary Artery DiseaseLast Updated:April 3, 2023Completed
Condition(s):Dyslipidemia; Atherosclerosis; Acute Coronary Syndrome; Cardiovascular DiseaseLast Updated:November 4, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.